Tag: healthcare insights

Industry Insight: Healthcare 17 May

Industry Insight: Healthcare

This week’s Healthcare Industry Insights focuses on innovations in breast cancer vaccines, key results from the recently published Global Burden of Disease 2021 study, and the results of a study looking at how proteins in the blood could be an early cancer warning.    The race for a breast cancer vaccineThere have been noticeable developments […]

Industry Insight: Healthcare 8 April

Industry Insight: Healthcare

This week’s Healthcare Industry Insights focuses on changes to China’s medical-device industry, users’ experiences with health-related content on Youtube, and FDA approval for a new antibiotic. China’s medical device industry gets a makeover This Nature article (part of Nature Spotlight: Medical devices in China) highlights the intensified push by the Chinese Government to produce and […]

Industry Insight: Healthcare 15 March

Industry Insight: Healthcare

Industry Insight: Healthcare 15 March This week our Healthcare Industry Insights focuses on a new approval indication for Novo Nordisk’s Wegovy, a pending decision on donanemab for Alzheimers, and potential withdrawal of the ALS drug, Relyvrio.  FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight Semaglutide […]

Industry Insight: Healthcare 22 February

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week, our Healthcare Industry Insight looks at positive pre-clinical results for THIO, an investigational telomere targeting agent, in small-cell lung cancer. We also take a look at new FDA drug approvals for advanced melanoma and food allergens. […]

Industry Insights: Healthcare 31 January

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week, our Industry Insights post looks at three important updates from the U.S. Food and Drug Administration (FDA). The FDA has investigated the risk of T-cell malignancy following BCMA-directed or CD19-directed autologous chimeric antigen receptor (CAR) T-cell […]

Industry Insights: Healthcare 18 December

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights focus on a major breakthrough for severe asthma treatment, three-year follow-up data from the phase 2b randomised KEYNOTE-942-/mRNA-4157-P201 study, and a new clinical trial looking at stem cell-based treatment for blood glucose control […]

Industry Insights: Healthcare 28 November

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights look at the U.S Food and Drug Administration (FDA) approval of Zepbound (tirzepatide) for chronic weight management, a World Health Organisation (WHO) statement on reported clusters of respiratory illness in children in northern […]

Industry Insights: Healthcare 6 November

Industry Insight: Healthcare

This week our Industry Insights: Healthcare looks at the potential for Food and Drug Administration (FDA) approval of CRISPR for sickle cell anaemia, new lung cancer screening guidelines by the American Cancer Society, and FDA approval for Phathom’s Voquezna. A panel of external advisors to the FDA has found the safety data for Exagamglogene Autotemcel […]

Industry Insights: Healthcare 25 September

Industry Insight: Healthcare

This week our industry insights look at news highlighting the importance of full disclosure in the promotion of medicines, EU recommendation for the approval of an antibody-drug for the treatment of NSCLC, and a popular oral decongestant that could be removed from the US market. Novartis has been found to have seriously breached the ABPI […]

Industry Insights: Healthcare 11 September

Industry Insight: Healthcare

This week, our industry news insights looks at an announcement of a new phase III trial for non-small cell lung cancer, artificial intelligence (AI) for breast cancer detection, and dramatic increases in cancer rates for under-50s. Taiho Oncology and Cullian Oncology have announced the phase III trial of zipalertinib in EGFR exon 20 insertion mutation […]

Industry insights: Healthcare 28th of August

Industry Insight: Healthcare

Here are three briefly summarised articles to help keep you informed of the latest developments in the industry. This week take a look at new US Government funding into vaccines and therapies for COVID and FDA clearance for new AI technology to help spot lung nodules. We also explore the impact of Keytruda (pembrolizumab) in […]